Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release
Product Images NDC 63629-9481

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, And Amphetamine Sulfate Extended-release (NDC 63629-9481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Amphetamine 01)

This is a chart showing the plasma concentrations of dextro and levoamphetamine at different intervals of time after taking dextroamphetamine or levoamphetamine in the form of extended-release capsules. The doses of dextroamphetamine and levoamphetamine were 20mg per day and 10mg twice a day respectively.*

FDA Label Image

Label (Lbl636299481)

This is a medication guide containing information about a drug called "Mixed Amphetamine Salts ER Capsules". It is a prescription-only medication and each capsule contains a mixture of four active ingredients that are amphetamines. The medication should be stored at a temperature between 20° to 25°C (68° to 77°F), in a tightly-closed, light-resistant container, out of reach of children. Pharmacists should dispense an accompanying medication guide to each patient. The National Drug Code (NDC) for this drug is 63629-9481-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.